Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
Sales | 123,562 | 117,246 | 123,652 | 103,698 | 97,131 |
Cost of Goods | 3,791 | 852 | 336 | 232 | 889 |
Gross Profit | 119,771 | 116,394 | 123,316 | 103,466 | 96,242 |
Operating Expenses | 77,418 | 54,104 | 55,764 | 49,397 | 47,093 |
Operating Income | 43,144 | 63,142 | 67,888 | 54,301 | 50,038 |
Other Income | 3,253 | 3,310 | 4,409 | 4,838 | 4,397 |
Pre-tax Income | 46,397 | 66,452 | 72,297 | 59,139 | 54,435 |
Income Tax | 17,631 | 25,252 | 27,703 | 20,699 | 19,052 |
Net Income Continuous | 28,766 | 41,200 | 44,594 | 38,440 | 35,383 |
Net Income | $28,766 | $41,200 | $44,594 | $38,440 | $35,383 |
EPS Basic Total Ops | 0.18 | 0.27 | 0.28 | 0.25 | 0.23 |
EPS Basic Continuous Ops | 0.19 | 0.27 | 0.29 | 0.25 | 0.23 |
EPS Diluted Total Ops | 0.17 | 0.24 | 0.26 | 0.22 | 0.20 |
EPS Diluted Continuous Ops | 0.16 | 0.23 | 0.26 | 0.22 | 0.20 |
EBITDA(a) | $46,147 | $66,242 | $70,758 | $57,047 | $52,686 |